New investor pres with B-vaxx update, page-4

Well spotted Kates,

That indicates the theory that over time B cells therapies can be a treatment or indeed a cure for cancer. Remember that initially patients on cancer immunotherapies tend to see tumours increase in size before reducing.

Before from 10 we had 5 with greater than 30% tumour reduction, with 4 stable (who might have a reduced tumour size, just not as much as 30%).

Now (from an unknown number) we have somebody who has a complete response, so that's perfect. Also an extra person with a greater than 30% tumour reduction.

So the numbers do appear to be getting better. Bare in mind that these people have metastasized cancers - so they really are on death row.

And all this and no safety issues at all. Fantastic.

How imu only have a $40m enterprise value is bizarre. I've seem lesser companies have a $300m market cap before. But one day it will change, looking at those results.

cheers